Showing results (1-10 of 155) with videos related to
Sort By:
Pageof 16
Experimental and Clinical Psychopharmacology|December 18, 2008
Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify)Jack BergmanThe British Journal of Clinical Psychology|November 9, 2004
Brief cognitive therapy of nightmares and post-traumatic ruminations in a man with a learning disabilityPaul WillnerNeuropsychobiology|July 23, 2005
Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMSPaul WillnerNeurobiology of Stress|February 24, 2017
Reliability of the chronic mild stress model of depression: A user surveyPaul WillnerJournal of Intellectual Disability Research : JIDR|January 29, 2014
The neurobiology of aggression: implications for the pharmacotherapy of aggressive challenging behaviour by people with intellectual disabilitiesPaul WillnerNeurobiology of Stress|February 24, 2017
The chronic mild stress (CMS) model of depression: History, evaluation and usagePaul WillnerJournal of Medical Ethics|August 7, 2017
The UK Mental Capacity Act and consent to research participation: asking the right questionPaul WillnerPsychopharmacology|August 21, 2015
Treatment-resistant depression: are animal models of depression fit for purpose?Paul Willner, Catherine BelzungCurrent Protocols|March 9, 2023
Models of Affective Illness: Chronic Mild Stress in the RatMariusz Papp, Paul WillnerBehavioural and Cognitive Psychotherapy|February 22, 2011
Magical thinking in obsessive-compulsive disorder and generalized anxiety disorderBonnie West, Paul WillnerPageof 16